Last reviewed · How we verify
SCTG
At a glance
| Generic name | SCTG |
|---|---|
| Sponsor | The University of Texas Health Science Center, Houston |
| Modality | Biologic |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Taking Measurements of a Gum Graft Site as it Heals
- VCMX, PRF and SCTG Treatment in the Gingival Recessions (PHASE3)
- Evaluation of the Clinical Efficacy of De-Epithelialized Free Gingival Graft in the Treatment of Gingival Recessions (NA)
- Clinical Outcomes of Enamel Matrix Derivative and Connective Tissue Graft in Modified Coronally Advanced Tunnel (MCAT) (NA)
- Behavioral Comparison of Three Different Graft Materials to Increase Soft Tissue Thickness Around Dental Implants. (PHASE4)
- Optimizing Clinical Outcomes in CAF + SCTG: the Impact of Compressive Sutures (NA)
- Comparing Two Different Tunneling Technique for Gingival Recession Treatment Using Two Different Matertial (NA)
- Volumetric Analysis of Alveolar Ridge Contour Using Sub-epithelial Connective Tissue Graft (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SCTG CI brief — competitive landscape report
- SCTG updates RSS · CI watch RSS
- The University of Texas Health Science Center, Houston portfolio CI